.css-py4oh{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-500);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-py4oh:not([data-theme]),[data-theme=dark] .css-py4oh:not([data-theme]),.css-py4oh[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-py4oh{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Frank Kirchhoff

Ulm / DE

Ulm University Medical Center

Chair

28/03/2023
15:45 – 17:15
Workshop
Innate immunity 1
Lecture hall 4/5

Further involvements as author

28/03/2023
Poster
P 320
High replicative fitness and potent immune receptor modulation of the highly virulent HIV-1 variant
Clinical virology, Viral pathogenesis and persistence
28/03/2023
Poster
P 211
Characterization of extracellular vesicles from various body fluids that show broad antiviral activities
Innate immunity, Host cell factors and modulation
28/03/2023
Poster
P 232
Functional impact of Spike mutations in SARS-CoV-2 Omicron lineages
Virus receptors and entry, SARS-CoV-2
28/03/2023
Poster
P 203
SARS-CoV-2 spike and orf7a downregulate the host restriction factor BST2/tetherin
SARS-CoV-2, Innate immunity
28/03/2023
Poster
P 263
Impact of human ACE2 N-glycosylation on SARS-CoV-2 spike-mediated infection
SARS-CoV-2, Structure, assembly, egress
28/03/2023
Poster
P 037
Human endogenous peptides derived from hemoglobin alpha reduce pro-viral autophagy
Antiviral therapy and resistance, Innate immunity
28/03/2023
Poster
P 018
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5 that can be predicted by anti-Spike antibody concentrations in serological assays
Adaptive immunity
28/03/2023
17:00 – 17:15 12 Min. 3 Min.
Abstract Talk
O 012
HIV-1 infection activates an endogenous solo-LTR regulating cellular senescence
Innate immunity, Host cell factors and modulation
28/03/2023
19:00 – 19:15 12 Min. 3 Min.
Abstract Talk
O 036
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Clinical virology, Antiviral therapy and resistance
28/03/2023
19:00 – 19:15 12 Min. 3 Min.
Abstract Talk
O 030
Novel factors linking autophagy and the interferon system
Innate immunity, Host cell factors and modulation
29/03/2023
10:45 – 11:00 12 Min. 3 Min.
Abstract Talk
O 044
Identification of new cellular target proteins of HIV-1 Vpu and Vpr using ubiquitinome profiling
Adaptive immunity
30/03/2023
08:30 – 08:45 12 Min. 3 Min.
Abstract Talk
O 079
An amyloidogenic fragment of human alpha-hemoglobin with combined antibacterial and antiviral activity
Antiviral therapy and resistance, Innate immunity
30/03/2023
14:00 – 14:15 12 Min. 3 Min.
Abstract Talk
O 093
Casein kinase 2 prevents virus-induced autophagy by phosphorylating filamin-NHL containing TRIM proteins
Innate immunity, Host cell factors and modulation
30/03/2023
14:00 – 14:15 12 Min. 3 Min.
Abstract Talk
O 087
SARS-CoV-2 Omicron Envelope T9I mutation enhances autophagy evasion
SARS-CoV-2, Innate immunity